Revvity Inc (RVTY)

$102.55 -0.71 (-0.69%)
Market Cap 11.65B
Revenue (ttm) 2.76B
Net Income (ttm) 270.39M
EPS (ttm) N/A
PE Ratio 21.38
Forward PE 20.84
Profit Margin 9.81%
Debt to Equity Ratio 0.44
Volume 1,108,370
Avg Vol 1,446,486
Day's Range N/A - N/A
Shares Out 113.38M
Stochastic %K 77%
Beta 1.06
Analysts Strong Sell
Price Target $113.07

Company Profile

Revvity, Inc. provides health sciences solutions, technologies, and services. The company provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and DNA sequencing services; and instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and sc...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 781 663 6900
Address:
77 4th Avenue, Waltham, United States
Iightning
Iightning Dec. 4 at 8:40 PM
1ightning® Premium Options Alert (Actionable) Ticker: $RVTY Contract: Dec 19 $105C Entry: 2.65 Exit: 4.94 Return: +86.23% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Dec. 4 at 5:57 PM
$RVTY I love these W formations Super bullish
0 · Reply
Iightning
Iightning Dec. 4 at 4:23 AM
1ightning® Premium Options Alert (Actionable) Ticker: $RVTY Contract: Dec 19 $105C Entry: 2.62 Exit: 4.28 Return: +63.24% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 4 at 1:45 AM
$RVTY Current Stock Price: $103.22 Contracts to trade: $105 RVTY Dec 19 2025 Call Entry: $0.55 Exit: $0.80 ROI: 45% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Dec. 3 at 4:06 PM
$RVTY They have something nobody else has in this space AI software …SIGNAl No doubt someone will acquire them very soon most likely in the $150-$160 range
0 · Reply
Iightning
Iightning Dec. 3 at 8:51 AM
1ightning® Premium Options Alert (Actionable) Ticker: $RVTY Contract: Dec 19 $80C Entry: 17.45 Exit: 28.00 Return: +60.46% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Dec. 2 at 2:39 PM
$RVMD $RVTY $RXST $RYAAY $RYAN Undeniable Accuracy Cycle Trading Signal plugged into AI 🔥 lists 🔥
0 · Reply
Iightning
Iightning Dec. 1 at 10:34 PM
**1ightning® Premium Options Alert (Actionable)** **Ticker:** $RVTY **Contract:** Dec 19 $105C **Entry:** 1.92 **Exit:** 3.04 **Return:** **+58.48% ROI** This is the level of accuracy our VIP desk delivers daily. If you want **institutional-grade scalps without the noise**, join us. **Unlock VIP Access → https://1ightning.com**
0 · Reply
Iightning
Iightning Nov. 26 at 1:21 AM
1ightning® Options Trade Alert (Actionable) | Buy $RVTY Dec 19 $105 Call | Enter: $2.17 Exit: $3.43 | Profit: 57.93% ROI | https://1ightning.com
0 · Reply
boston_drew
boston_drew Nov. 25 at 3:58 PM
$RVTY It's obvious a buy out offer coming - probably $150
0 · Reply
Latest News on RVTY
Revvity, Inc. (RVTY) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Dec 2, 2025, 12:53 PM EST - 2 days ago

Revvity, Inc. (RVTY) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Revvity, Inc. (RVTY) Presents at Jefferies London Healthcare Conference 2025 Transcript

Nov 18, 2025, 11:38 AM EST - 16 days ago

Revvity, Inc. (RVTY) Presents at Jefferies London Healthcare Conference 2025 Transcript

Revvity, Inc. (RVTY) Presents at UBS Global Healthcare Conference 2025 Transcript

Nov 10, 2025, 10:11 AM EST - 24 days ago

Revvity, Inc. (RVTY) Presents at UBS Global Healthcare Conference 2025 Transcript

Revvity Collaborates with MDIC and NIST to Launch New Somatic Cancer Reference Standards to Monitor Diagnostic Assay Accuracy

Nov 10, 2025, 8:00 AM EST - 24 days ago

Revvity Collaborates with MDIC and NIST to Launch New Somatic Cancer Reference Standards to Monitor Diagnostic Assay Accuracy

Revvity to Acquire ACD/Labs to Expand its Signals Software Capabilities

Nov 10, 2025, 7:45 AM EST - 24 days ago

Revvity to Acquire ACD/Labs to Expand its Signals Software Capabilities

Revvity Analysts Increase Their Forecasts After Q3 Earnings

Oct 28, 2025, 9:32 AM EDT - 5 weeks ago

Revvity Analysts Increase Their Forecasts After Q3 Earnings

Revvity to Present at Upcoming Investor Conferences

Oct 28, 2025, 8:00 AM EDT - 5 weeks ago

Revvity to Present at Upcoming Investor Conferences

Revvity: Software Momentum And Screening Offset China Weakness

Oct 27, 2025, 12:56 PM EDT - 5 weeks ago

Revvity: Software Momentum And Screening Offset China Weakness

Revvity, Inc. (RVTY) Q3 2025 Earnings Call Transcript

Oct 27, 2025, 12:47 PM EDT - 5 weeks ago

Revvity, Inc. (RVTY) Q3 2025 Earnings Call Transcript

Revvity lifts annual profit forecast on renewed demand in diagnostics unit

Oct 27, 2025, 7:06 AM EDT - 5 weeks ago

Revvity lifts annual profit forecast on renewed demand in diagnostics unit

Revvity Announces Financial Results for the Third Quarter of 2025

Oct 27, 2025, 6:00 AM EDT - 5 weeks ago

Revvity Announces Financial Results for the Third Quarter of 2025

Revvity Board Declares Quarterly Dividend

Oct 23, 2025, 4:05 PM EDT - 6 weeks ago

Revvity Board Declares Quarterly Dividend

Revvity Showcases Progress with Purpose in 2025 Impact Report

Oct 14, 2025, 8:00 AM EDT - 7 weeks ago

Revvity Showcases Progress with Purpose in 2025 Impact Report

Revvity to Hold Earnings Call on Monday, October 27, 2025

Oct 6, 2025, 8:00 AM EDT - 2 months ago

Revvity to Hold Earnings Call on Monday, October 27, 2025

Revvity Announces Program to Revolutionize the Early Detection of Type 1 Diabetes

Oct 2, 2025, 8:00 AM EDT - 2 months ago

Revvity Announces Program to Revolutionize the Early Detection of Type 1 Diabetes

SNY

Revvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis

Sep 29, 2025, 8:00 AM EDT - 2 months ago

Revvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis

Revvity and Profluent Collaborate to Launch AI-Enhanced Adenine Deaminase Pin-point Base Editing Systems

Sep 22, 2025, 8:00 AM EDT - 2 months ago

Revvity and Profluent Collaborate to Launch AI-Enhanced Adenine Deaminase Pin-point Base Editing Systems

Revvity, Inc. (RVTY) Presents At Baird 2025 Global Healthcare Conference (Transcript)

Sep 9, 2025, 5:31 PM EDT - 3 months ago

Revvity, Inc. (RVTY) Presents At Baird 2025 Global Healthcare Conference (Transcript)

Revvity, Inc. (RVTY) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Sep 3, 2025, 10:40 AM EDT - 3 months ago

Revvity, Inc. (RVTY) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Revvity Establishes In Vivo Imaging Center of Excellence in North Carolina

Sep 2, 2025, 8:00 AM EDT - 3 months ago

Revvity Establishes In Vivo Imaging Center of Excellence in North Carolina

Revvity Launches Innovative Reagent Technology to Accelerate Development of Next-Generation Targeted Therapeutics

Aug 6, 2025, 8:00 AM EDT - 4 months ago

Revvity Launches Innovative Reagent Technology to Accelerate Development of Next-Generation Targeted Therapeutics

Revvity Q2: Headwinds From China And Customers, Buy On Weakness

Jul 28, 2025, 2:47 PM EDT - 4 months ago

Revvity Q2: Headwinds From China And Customers, Buy On Weakness

Revvity Stock Sinks on Lowered China Immunodiagnostics Outlook

Jul 28, 2025, 1:40 PM EDT - 4 months ago

Revvity Stock Sinks on Lowered China Immunodiagnostics Outlook

Top Stock Movers Now: Nike, Cheniere Energy, Revvity, and More

Jul 28, 2025, 12:25 PM EDT - 4 months ago

Top Stock Movers Now: Nike, Cheniere Energy, Revvity, and More

LNG NKE

Revvity, Inc. (RVTY) Q2 2025 Earnings Call Transcript

Jul 28, 2025, 11:59 AM EDT - 4 months ago

Revvity, Inc. (RVTY) Q2 2025 Earnings Call Transcript

ATAI Life Sciences, Revvity And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Jul 28, 2025, 8:13 AM EDT - 4 months ago

ATAI Life Sciences, Revvity And Other Big Stocks Moving Lower In Monday's Pre-Market Session

ATAI

Revvity trims 2025 profit forecast on soft demand for diagnostics in China

Jul 28, 2025, 8:09 AM EDT - 4 months ago

Revvity trims 2025 profit forecast on soft demand for diagnostics in China

Revvity Stock Tumbles After Earnings. What's Dragging on the Shares.

Jul 28, 2025, 7:39 AM EDT - 4 months ago

Revvity Stock Tumbles After Earnings. What's Dragging on the Shares.

Revvity Q2 Revenue Up 4 Percent

Jul 28, 2025, 7:34 AM EDT - 4 months ago

Revvity Q2 Revenue Up 4 Percent

Revvity Announces Financial Results for the Second Quarter of 2025

Jul 28, 2025, 6:00 AM EDT - 4 months ago

Revvity Announces Financial Results for the Second Quarter of 2025

Revvity to Hold Earnings Call on Monday, July 28, 2025

Jul 7, 2025, 8:00 AM EDT - 5 months ago

Revvity to Hold Earnings Call on Monday, July 28, 2025

Revvity Introduces New IVD Reference Standards for Monitoring Oncology Diagnostic Testing Workflows

Jun 2, 2025, 8:00 AM EDT - 6 months ago

Revvity Introduces New IVD Reference Standards for Monitoring Oncology Diagnostic Testing Workflows

Revvity's EUROIMMUN Unveils New Fully Automated Instrument for Specialty Testing

May 19, 2025, 8:00 AM EDT - 7 months ago

Revvity's EUROIMMUN Unveils New Fully Automated Instrument for Specialty Testing

Revvity: Despite Facing Multiple Headwinds, Shares Are A Buy

May 9, 2025, 10:35 AM EDT - 7 months ago

Revvity: Despite Facing Multiple Headwinds, Shares Are A Buy

Revvity, Inc. (RVTY) Q1 2025 Earnings Call Transcript

Apr 28, 2025, 11:49 AM EDT - 7 months ago

Revvity, Inc. (RVTY) Q1 2025 Earnings Call Transcript

Life Science Tools Maker Revvity Delivers Strong Q1 Earnings Despite Evolving Macroeconomic Backdrop

Apr 28, 2025, 9:14 AM EDT - 7 months ago

Life Science Tools Maker Revvity Delivers Strong Q1 Earnings Despite Evolving Macroeconomic Backdrop

Revvity beats quarterly estimates on steady demand for medical equipment

Apr 28, 2025, 7:32 AM EDT - 7 months ago

Revvity beats quarterly estimates on steady demand for medical equipment

Revvity Announces Financial Results for the First Quarter of 2025

Apr 28, 2025, 6:00 AM EDT - 7 months ago

Revvity Announces Financial Results for the First Quarter of 2025

Watchmaker Genomics and Revvity Team to Automate and Streamline NGS Library Preparation

Apr 23, 2025, 8:00 AM EDT - 8 months ago

Watchmaker Genomics and Revvity Team to Automate and Streamline NGS Library Preparation

Revvity Fuels the Future of Cancer Science with New Research Solutions

Apr 22, 2025, 8:00 AM EDT - 8 months ago

Revvity Fuels the Future of Cancer Science with New Research Solutions

RSSS

Revvity to Hold Earnings Call on Monday, April 28, 2025

Apr 3, 2025, 8:00 AM EDT - 8 months ago

Revvity to Hold Earnings Call on Monday, April 28, 2025

Revvity Signals Software Unveils Unified Data Platform to Accelerate Drug Discovery

Apr 2, 2025, 8:00 AM EDT - 8 months ago

Revvity Signals Software Unveils Unified Data Platform to Accelerate Drug Discovery

Revvity Secures FDA Approval for Improved Automated Latent Tuberculosis Test

Apr 2, 2025, 8:00 AM EDT - 8 months ago

Revvity Secures FDA Approval for Improved Automated Latent Tuberculosis Test

Revvity Expands Alliance with Genomics England to Drive Research into Newborn Genomic Sequencing in England

Mar 20, 2025, 1:00 PM EDT - 9 months ago

Revvity Expands Alliance with Genomics England to Drive Research into Newborn Genomic Sequencing in England

PerkinElmer Acquires Project Farma, Expanding Its OneSource Professional Services Offering for the Life Sciences Industry

Mar 11, 2025, 12:00 PM EDT - 9 months ago

PerkinElmer Acquires Project Farma, Expanding Its OneSource Professional Services Offering for the Life Sciences Industry

Revvity's EUROIMMUN Receives CE Mark for Novel Measles Antibody Detection Assay

Mar 3, 2025, 8:00 AM EST - 9 months ago

Revvity's EUROIMMUN Receives CE Mark for Novel Measles Antibody Detection Assay

Revvity Wins Permanent Injunction Enforcing Agreements with Cloud Software Group

Feb 20, 2025, 12:30 PM EST - 10 months ago

Revvity Wins Permanent Injunction Enforcing Agreements with Cloud Software Group

Revvity, Inc. (RVTY) Q4 2024 Earnings Call Transcript

Jan 31, 2025, 9:34 AM EST - 10 months ago

Revvity, Inc. (RVTY) Q4 2024 Earnings Call Transcript

Revvity forecasts 2025 revenue, profit below estimates amid weak biotech spending

Jan 31, 2025, 7:32 AM EST - 10 months ago

Revvity forecasts 2025 revenue, profit below estimates amid weak biotech spending

Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2024

Jan 31, 2025, 6:00 AM EST - 10 months ago

Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2024

Iightning
Iightning Dec. 4 at 8:40 PM
1ightning® Premium Options Alert (Actionable) Ticker: $RVTY Contract: Dec 19 $105C Entry: 2.65 Exit: 4.94 Return: +86.23% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Dec. 4 at 5:57 PM
$RVTY I love these W formations Super bullish
0 · Reply
Iightning
Iightning Dec. 4 at 4:23 AM
1ightning® Premium Options Alert (Actionable) Ticker: $RVTY Contract: Dec 19 $105C Entry: 2.62 Exit: 4.28 Return: +63.24% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 4 at 1:45 AM
$RVTY Current Stock Price: $103.22 Contracts to trade: $105 RVTY Dec 19 2025 Call Entry: $0.55 Exit: $0.80 ROI: 45% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Dec. 3 at 4:06 PM
$RVTY They have something nobody else has in this space AI software …SIGNAl No doubt someone will acquire them very soon most likely in the $150-$160 range
0 · Reply
Iightning
Iightning Dec. 3 at 8:51 AM
1ightning® Premium Options Alert (Actionable) Ticker: $RVTY Contract: Dec 19 $80C Entry: 17.45 Exit: 28.00 Return: +60.46% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Dec. 2 at 2:39 PM
$RVMD $RVTY $RXST $RYAAY $RYAN Undeniable Accuracy Cycle Trading Signal plugged into AI 🔥 lists 🔥
0 · Reply
Iightning
Iightning Dec. 1 at 10:34 PM
**1ightning® Premium Options Alert (Actionable)** **Ticker:** $RVTY **Contract:** Dec 19 $105C **Entry:** 1.92 **Exit:** 3.04 **Return:** **+58.48% ROI** This is the level of accuracy our VIP desk delivers daily. If you want **institutional-grade scalps without the noise**, join us. **Unlock VIP Access → https://1ightning.com**
0 · Reply
Iightning
Iightning Nov. 26 at 1:21 AM
1ightning® Options Trade Alert (Actionable) | Buy $RVTY Dec 19 $105 Call | Enter: $2.17 Exit: $3.43 | Profit: 57.93% ROI | https://1ightning.com
0 · Reply
boston_drew
boston_drew Nov. 25 at 3:58 PM
$RVTY It's obvious a buy out offer coming - probably $150
0 · Reply
Iightning
Iightning Nov. 25 at 11:28 AM
1ightning® Options Trade Alert (Actionable) | Buy $RVTY Dec 19 $105 Call | Enter: $2.17 Exit: $3.43 | Profit: 57.93% ROI | https://1ightning.com
0 · Reply
Arcides
Arcides Nov. 25 at 1:48 AM
$RVTY the highest volume in a year today on this one today
0 · Reply
Iightning
Iightning Nov. 25 at 12:23 AM
1ightning® Options Trade Alert (Actionable) | Buy $RVTY Dec 19 $105 Call | Enter: $2.17 Exit: $3.43 | Profit: 57.93% ROI | https://1ightning.com
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 23 at 5:27 PM
$RVMD $RVTY $RXST $RYAAY $RYAN 🔥
0 · Reply
Iightning
Iightning Nov. 21 at 9:40 PM
1ightning® Options Trade Alert (Actionable) | Buy $RVTY Dec 19 $95 Call | Enter: $4.07 Exit: $7.48 | Profit: 83.62% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 21 at 12:44 AM
1ightning® Options Trade Alert (Actionable) | Buy $RVTY Dec 19 $95 Call | Enter: $4.07 Exit: $7.48 | Profit: 83.62% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 19 at 10:15 PM
1ightning® Options Trade Alert (Actionable) | Buy $RVTY Dec 19 $95 Call | Enter: $4.07 Exit: $7.48 | Profit: 83.62% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 19 at 6:37 AM
1ightning® Options Trade Alert (Actionable) | Buy $RVTY Dec 19 $95 Call | Enter: $4.07 Exit: $7.48 | Profit: 83.62% ROI | https://1ightning.com
0 · Reply
LandonCapital
LandonCapital Nov. 10 at 1:23 PM
$RVTY https://landoncapital.net/lets-make-a-deal-revvity-nyse-rvty-to-acquire-acd-labs/
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Oct. 27 at 3:07 PM
$RVTY 3% growth w a forward PE over 20 …overvalued
0 · Reply
Parched_River_Capital
Parched_River_Capital Oct. 27 at 2:57 PM
$RVTY why is this down? didn't they beat on earnings?
0 · Reply
OpenOutcrier
OpenOutcrier Oct. 27 at 12:49 PM
$RVTY (-2.9% pre) Revvity: Q3 Earnings Snapshot https://ooc.bz/l/81956
0 · Reply